U.S. · HEALTH · NOV 10, 4:48 AM ET
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
Reported by 29 outlets in the past day, including CNBC, CBS News, STAT.
1What happened
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes. CNBC ↗
2Also reported
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands. CBS News ↗
Sources
- FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound ↗CNBC
- FDA warns of rare vision-loss side effect from GLP-1 drugs ↗CBS News
- STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition ↗STAT
- FDA tells GLP-1 makers to warn of potential vision loss side effect ↗The Washington Post
- GLP-1 drugs, popular for weight loss, get FDA warning of rare vision-loss side effect ↗CBS News